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JBehavioral counseling interventions to promote healthy behaviors can signiﬁcantly reduce leading
causes of disease and death. Recommendations for delivery of these interventions in primary care
have been and continue to be an important part of the U.S. Preventive Services Task Force’s portfolio
of clinical preventive services recommendations. However, primary and secondary research on the
effectiveness of behavioral counseling interventions can be more complex than recommendations
for screening or use of preventive medications. The nature of behavior change and interventions to
promote it can lead to unique challenges. This paper summarizes and expands upon an extensive
discussion held at the U.S. Preventive Services Task Force’s Expert Forum on behavioral counseling
interventions held in November 2013. The paper describes the foundational challenges for using
behavioral outcomes as evidence to support a Task Force recommendation. The paper discusses
research design and reporting characteristics needed by behavioral counseling intervention
researchers in order for their research to contribute to the evidentiary basis of a Task Force
recommendation. Finally, the paper identiﬁes critical issues that need to be considered by the Task
Force and other stakeholders to maintain conﬁdence and credibility in the standards of evidence for
behavioral counseling recommendations.
(Am J Prev Med 2015;49(3S2):S150–S157) & 2015 American Journal of Preventive Medicine. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).IntroductionBehavioral counseling interventions to promotehealthy behaviors can signiﬁcantly reduce leadingcauses of morbidity and mortality, including heart
disease and cancer. Recommendations for behavioral
counseling interventions have been an integral part of
the U.S. Preventive Services Task Force’s (USPSTF’s)
portfolio of recommendations since its ﬁrst report in
1989.1 However, the evidence base and evidence stand-
ards in behavioral medicine have evolved over the past 25
years.2–4 The USPSTF has well-deﬁned methods and
standards for evaluating evidence of effectiveness for
preventive services such as screening and use of pre-
ventive medications. It has adapted those methods to
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behavioral counseling research and systematic reviews of
complex behavioral interventions.5,6
In November 2013, the USPSTF convened an Expert
Forum of behavioral counseling experts, researchers,
funders, and USPSTF members to engage the research
community and address critical questions about the
USPSTF’s approach to behavioral counseling topics.
One of the essential questions the group was asked to
consider was whether the standards of evidence for
assessing the net beneﬁt of counseling interventions
should be the same as for other preventive services such
as screening tests and use of preventive medications.
Several related questions were considered as well: Should
behavioral outcomes (e.g., change in behavior such as
smoking cessation) be distinguished from other types of
outcomes (e.g., modiﬁcation of risk factors such as
weight loss or health outcomes such as depression)? On
what, if any, basis should behavioral outcomes be
considered sufﬁcient for an evidence-based recommen-
dation? What are the important harms or unintended
consequences associated with behavioral interventions in
primary care settings? What should be assumed about
the severity of harm when evidence is lacking? This
paper summarizes and expands on these discussions. Itn Journal of Preventive Medicine  Published by Elsevier Inc. This
-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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outcomes as sufﬁcient evidence to make a recommenda-
tion, discusses the ideal characteristics of research design
and implementation to support evidence-based behav-
ioral counseling recommendations, and offers sugges-
tions for future consideration.
Issues of Concern
Linking Behavior Change and Health Outcomes
The USPSTF’s recommendations are based on scientiﬁc
evidence that people who receive the preventive service
experience better health outcomes than those who do
not. In addition, the beneﬁts must be large enough to
outweigh the harms.7 The USPSTF looks for evidence to
support speciﬁc linkages in the analytic framework
(Figure 1), but overall a complete causal chain from
intervention to outcome must be supported by evidence.
Outcomes that patients can feel or care about (e.g., pain,
function, survival) are weighted more heavily than
intermediate or surrogate outcomes. Behavioral counsel-
ing intervention recommendations are generally
expected to meet the same standards of evidence for
linking interventions and health outcomes, but the
nature of behavior change and interventions to promote
it leads to some unique challenges compared with
evidence for screening or use of preventive medications.
Time to outcome is one important challenge. The time
frame for identifying a link between sustained behavior
change and a health outcome can be as long as 10–20
years, and even longer in interventions targetingFigure 1. Analytic framework for behavioral counseling interven
Note: Key questions: 1. Do changes in patients’ health behavior improve hea
health behavior change and health improvement (i.e., minimum duration, mi
the adverse effects of health behavior change? 4. Does health behavior chan
other health care behaviors, improved function, and decreased use of he
improvement associated with reduced morbidity or mortality? 6. Is susta
mortality? 7. Are behavioral counseling interventions in clinical care related
counseling interventions in clinical care related directly to reduced morbidit
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September 2015children. For example, eating a healthful diet and
engaging in physical activity may lower the risk of
obesity and hypertension, but it may take decades for
the cardiovascular morbidity and mortality beneﬁts to
emerge. Likewise, stopping smoking can have immediate
health beneﬁts, including reductions in cardiovascular
disease risks, but the long-term beneﬁts of reduction in
lung cancer, chronic obstructive pulmonary disease, and
cardiovascular disease will not appear for many years.
Most RCTs do not have long enough follow-up periods
to demonstrate these important linkages between the
behavioral outcome (e.g., stopping smoking) and the
health outcome (e.g., lung cancer).
The target population for USPSTF behavioral coun-
seling recommendations presents another challenge for
linking behavioral outcomes and health outcomes. The
USPSTF recommendations apply only to asymptomatic
individuals or to those with unrecognized signs or
symptoms of the target condition for which the preven-
tive service is intended. These individuals may also be at
lower risk for the condition being prevented. Effective
behavioral counseling interventions can disrupt the
natural history of the behavior–disease relationship and
lead to continued low rates of morbidity and mortality.
However, continued low outcome event rates in low-risk
people make it difﬁcult to demonstrate beneﬁts. For
example, although behavioral counseling interventions
for improving diet and exercise in average-risk individ-
uals showed changes in healthy behaviors (e.g., increased
fruit and vegetable intake, increase minutes of exercise)
and improvements in intermediate outcomes (e.g.,tions.
lth or reduce risk factors? 2. What is the relationship between duration of
nimum level of change, and change–response relationship)? 3. What are
ge produce other positive outcomes (e.g., patient satisfaction, changes in
alth care resources)? 5. Is risk factor reduction or measured health
ined health behavior change related directly to reduced morbidity or
directly to improved health or risk factor reduction? 8. Are behavioral
y or mortality?
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meant there was not a strong linkage with health
outcomes.
Given the intrinsic challenges of demonstrating the
linkages between behavioral outcomes and longer-term
health outcomes, the USPSTF will consider the quality of
the evidence for individual linkages in the causal chain, as
well as epidemiologic evidence that may augment sparse
trial data. For example, consistent ﬁndings from large-
scale longitudinal studies that demonstrate linkages
between behavior and health would contribute to a
cohesive body of evidence. If the USPSTF were willing
to accept behavioral outcomes as sufﬁcient evidence of
effectiveness, what are the ideal characteristics of the
research needed to make an evidence-based determina-
tion around counseling interventions? The next section of
the paper describes the key considerations and challenges
of the research quality and evaluation of the evidence
itself. Although many of these considerations are not
unique to the behavioral counseling literature, explicitly
highlighting the differences could help guide researchers
as they design and implement their studies; funders as
they prioritize investment in new research; and payers,
guideline developers, and other decision makers as they
create policies to disseminate best practices.Populations/Settings
Ideally, studies are conducted in populations and settings
that are closely representative of the target population, that
is, for whom they are intended in actual practice. The
USPSTF focuses on well-conducted trial-level evidence of
beneﬁt for counseling interventions in primary care. Often,
participants in these trials are not widely representative of
the community’s primary care population. Although this
issue of efﬁcacy versus effectiveness is not unique to
behavioral counseling trials, it can be exaggerated in this
evidence base, in that trials often have more-restrictive
inclusion criteria for entry into the study than the general
primary care population of interest.8 Participants may be
mostly or partially volunteers and may have high attrition
of eligible compared with enrolled participants. Problems
extrapolating from volunteer samples may be particularly
exaggerated in studies of behavior change, where patients
may view enrollment as a means to achieve their own
personal goal, desiring the added support and structure a
study could provide. Unfortunately, important information
about who is or is not enrolled, indicators or descriptors of
readiness to change, and other factors such as adherence
and degree of efﬁcacy are not commonly reported.
Just as certain trial populations’ ﬁndings might be less
applicable to wider practice, the applicability of the trial
settings is important as well. Because the USPSTF’s targetaudience is primary care clinicians, their recommenda-
tions center on behavioral counseling interventions that
can be readily delivered in or referred from primary care.
Interventions conducted in community settings like
schools, workplaces, and churches may not be applicable
to primary care practice. Community-based counseling
interventions may not be available for referral, and some
aspects of the intervention may simply be impossible to
replicate in primary care settings. For example, counsel-
ing interventions in settings in which there is an existing
social network may perform differently with groups of
strangers, or worksite settings may be able to provide
onsite activities such as lunchtime group walks, which
would not be useful in most primary care settings. Other
important setting details, like the years in which the study
took place and the geographic location may affect if and
how the evidence is considered, as behaviors and cultural
norms change over time and from place to place.
The primary population as well as any important
subpopulations of interest should be deﬁned a priori, that
is, before the start of the trial. Populations studied in
behavioral counseling trials can include a broad range of
participants, or can focus on narrow, targeted populations
(e.g., subpopulations at higher risk for bad health outcomes
or with a disproportionate need for counseling). Well-
conducted trials that include a broad range of participants
are helpful in understanding the overall efﬁcacy or
effectiveness of a counseling intervention. However, these
trials may be more costly to conduct and may have
underwhelming effects as a result of larger ﬁndings in the
whole population obscuring smaller subpopulation effects.
More often, a body of counseling literature consists of
a range of trials that target a variety of speciﬁc popula-
tions. For example, the USPSTF recommendation for
counseling to prevent sexually transmitted infections
(STIs) excluded primary trials conducted exclusively in
HIV-positive people.9 Although there are HIV-positive
individuals seen in primary care who need STI preven-
tion counseling, the behaviors and motivations in this
population were deemed unique to this subgroup; there-
fore, it is unreasonable to extrapolate ﬁndings from this
subgroup to a broader primary care population. Multiple
studies conducted in narrow populations will not neces-
sarily provide meaningful evidence for broader popula-
tion recommendations.Interventions
One of the distinguishing features of behavioral counsel-
ing interventions is that they are usually more complex
than other preventive services such as screening and use
of preventive medications. Clear reporting of the inter-
vention components is important, as is the intensity,www.ajpmonline.org
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ered the intervention; and the ﬁdelity of its delivery and
adherence of the participant to various components of
the intervention. This information is not routinely or
consistently reported. Without knowing this level of
detail, it is difﬁcult to assess the reproducibility of
ﬁndings. Many counseling interventions may appear to
be “one-offs,” such that there is limited evidence for
similar interventions. The more complex an intervention
is, the less likelihood there is for reproducibility.
The issue of aggregating “like” interventions is not
unique to counseling interventions. It is analogous to
understanding the preventive beneﬁt of a medication. For
example, would it be reasonable to group all medications
to lower cholesterol versus a speciﬁc class of medications
(e.g., statins); versus a speciﬁc drug (e.g., simvastatin);
versus a speciﬁc dose (e.g., simvastatin 40 mg); versus a
speciﬁc dose, frequency, duration (e.g., simvastatin 40 mg
daily for 12 months), when evaluating effectiveness of
chemoprevention? The challenges are magniﬁed with the
complexity of counseling interventions. For example,
within the healthy lifestyle counseling literature, even
those interventions restricted to similar populations (e.g.,
people with cardiovascular risk factors) and with a
similar primary aim (e.g., reduce cardiovascular disease),
the interventions varied widely in the messages (e.g.,
different dietary and physical activity targets); compo-
nents (e.g., diaries, goal setting, social support, problem
solving, motivational interviewing); adjuncts (e.g., low-
cost exercise opportunities, cooking demonstrations);
intensity (e.g., 30 minutes to greater than 20 hours);
and frequency and duration (e.g., single visit to weekly
sessions for more than 1 year).10 This level of detailed
reporting is necessary to aggregate and then compare
“like” counseling interventions and to be explicit about
what works. Additionally, details on the ﬁdelity of the
delivery of the intervention, who is delivering the
counseling, as well as the adherence of participants to
the intervention allow for judgment of the efﬁcacy versus
effectiveness of any particular intervention, and equally
important, awareness and consideration around imple-
mentation issues with counseling in real-world settings.
The USPSTF is primarily concerned with making
recommendations about whether behavioral counseling
works, but not necessarily which counseling interven-
tions work better (i.e., comparative effectiveness). This
means much of the behavioral counseling evidence in any
given topic may not be considered. The same principles
of needing adequate detail to understand the intervention
and compare “like” interventions are needed. Although
the USPSTF can provide some guidance on parameters
that increase the likelihood that counseling will be
effective (e.g., must be intensive rather than brief),September 2015comparative effectiveness trials are often better for
determining necessary and sufﬁcient components of
effective interventions. For implementation of counseling
interventions, researchers, payers, and other decision
makers are often interested in the minimal effective
counseling “dose” for any given behavior. In the
USPSTF’s recent recommendation for healthful diet
and physical activity to prevent cardiovascular disease,
they were able to identify a mean range of the number of
contacts reported but the evidence base did not allow
them to identify the minimal number of contacts in order
to be effective.11 Similarly, in a recent review of STI
counseling, it was clear that the interventions with the
most hours of contact were most consistently effective;
however, some lower-intensity interventions in well-
conducted trials were also effective, making it very
difﬁcult to identify a minimum threshold.12Comparison Groups
Commonly, details about the control group or compa-
rator intervention are not reported in behavioral coun-
seling trials. Ideally, control group descriptions will
parallel intervention descriptions, including details
around counseling messages/components, intensity, fre-
quency, and duration, if applicable. The distinctions
between “no care” or “usual care” versus “minimal”
intervention versus an “active” intervention need to be
clearly deﬁned. Control arms are often described as
“usual care,” which, depending on the years, location,
and setting performed, can be anything from “no care” to
an “active” intervention. As with other research charac-
teristics, this issue of adequate reporting around the
control group is not a unique challenge to the behavioral
counseling literature. However, unlike being referred for
a screening colonoscopy or receiving an immunization,
patients are not reliant on the recommendation or
guidance of a primary care clinician to initiate healthy
behavior changes, such that the usual care group
frequently engages in behavior change(s) as well.
Understanding what are “like” interventions allows for
more intelligent synthesis and comparison of results. For
example, trials in which usual care actually entails an
active intervention may show less beneﬁt (smaller effect
sizes) than trials using no or minimal intervention. In a
review of healthy lifestyle interventions for the USPSTF,
trials done more recently (in 2010s) showed a smaller
effect than older trials (from the 1990s).10 Some of this
reduced effect may be due to evolution in the standards
of care over time (i.e., some counseling versus no
counseling). In addition to advances in standards of
usual care, the evolution of public and community
awareness, incentives, and education around healthy
McNellis et al / Am J Prev Med 2015;49(3S2):S150–S157S154behaviors over time means that “usual care” is highly
dependent on temporal and geographic setting. Robust
reporting around control groups is essential particularly
across different healthcare systems. For example, in trials
conducted outside the U.S., the healthcare systems are
often substantially different, and “usual care” may differ
markedly from any U.S. standard.Outcomes
Ultimately, the desired beneﬁt of behavior change is
improvement in health outcomes, that is, those health
outcomes that can be experienced by an individual such as
better quality of life, less disease, or greater functional ability.
For the USPSTF, recommendations are issued based on the
magnitude and certainty of net beneﬁt on health outcomes,
as opposed to surrogate or intermediate outcomes.13 For
example, increased physical activity (a behavioral outcome)
may lead to decreased blood pressure (an intermediate
outcome), which ultimately would be expected to result in
decreased heart attacks or stroke or death (health outcomes).
However, the web of behavioral, intermediate, and health
outcomes and the relationship among them can be very
complex and time-dependent (Figure 2).
Ideally, primary trials need to deﬁne primary and
secondary outcomes of interest a priori. Too often, trials
report multiple outcomes, and therefore may be prone to
selective reporting bias. Even within a speciﬁc body of
literature, similar outcomes can be deﬁned and measured
using a variety of methods, which may not be compara-
ble. If the outcomes being measured and reported are not
health outcomes, it is important to understand the
evidence supporting the causal links of behavioral and
intermediate outcomes to health outcomes. For example,
identifying the evidence base to support an increase in
physical activity or a decrease in blood pressure changeFigure 2. An example of the complex relationships between be
Note: This ﬁgure demonstrates the complex relationships between behavio
example of diet and physical activity interventions.leading to decreased cardiovascular morbidity and mor-
tality is critical to establishing linkages. The necessity in
establishing the “link” between intermediate and health
outcomes is not unique to behavioral counseling studies.
However, it can be compounded, as counseling trials can
be costly and resource intensive if powered to detect
beneﬁts in health outcomes, especially if intended as
primary or secondary prevention (versus treatment).Measuring Behaviors
One of the greatest challenges in understanding the
clinical relevance of behavioral outcomes is the variability
in how behaviors are deﬁned and measured. For example,
physical activity can be deﬁned as minutes per week,
METs per week, or moderate or vigorous activity minutes
per week and can be reported as a change in number of
minutes per week (continuous) or change in number of
people meeting recommended number of minutes per
week (dichotomous). Interpreting the magnitude of
ﬁndings for continuous measures, especially more-
modest changes (e.g., increase in 20 minutes per week
of physical activity or 2-mmHg reduction in systolic
blood pressure), and their relationship to health out-
comes is very difﬁcult, and not established for many
behavioral or physiologic measures. Dichotomous out-
comes, although more clinically intuitive, are not com-
monly or consistently reported (e.g., reporting how many
participants met physical activity goals or had a blood
pressure less than 140/90 mmHg). Meaningful dichoto-
mous outcome thresholds are often not established or
agreed upon, leading to the inconsistency of how and if
these outcomes are reported. For example, abstinence has
been the most important treatment goal for alcohol,
tobacco, or illicit drug use, but there are also health
beneﬁts to reduction in use, not just abstinence, whichhavioral counseling interventions and outcomes.
ral outcomes, intermediate outcomes, and health outcomes using the
www.ajpmonline.org
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cal, standardization both of operational deﬁnitions and
types of reported outcomes is critical for comparing
results across studies.
From the measurement perspective, behavioral out-
comes can be self-reported (subjective) or objectively
measured. One is not inherently better than the other,
but each must be viewed in context. Although subjective
measures of behaviors (e.g., exercise log) cannot be
“blinded” and are subject to both recall and social
desirability bias, objective measures of behaviors (e.g.,
pedometer, VO2 max) may also be limited and may not
be more clearly associated with health outcomes. Both
subjective and objective measures of behavior changes
should be validated in the population being studied.
Often, a combination of complementary outcomes meas-
ures is helpful; for example, concordant changes (in
magnitude and direction of effect) in multiple measures
of a single behavior or measures of multiple behaviors is a
more robust ﬁnding in favor of a counseling intervention
than discordant changes across different outcomes.
Consistent ﬁndings of beneﬁcial behavioral outcomes
and positive change in intermediate outcomes (i.e.,
physiologic measures), regardless of how the outcome
is measured, lead to a more robust evidence base.Assessing Harms
Harms are an underappreciated and under-reported
outcome; again, the phenomenon is not limited to
behavioral counseling literature. When determining
“net” beneﬁt, the USPSTF assesses the magnitude of
the health beneﬁt in relation to the harms of the
intervention. Although the harms of other preventive
services have been well delineated (e.g., overdiagnosis,
complications from testing or subsequent diagnostic
testing, adverse drug events), the actual and potential
harms of behavioral counseling interventions have been
less well described. Counseling interventions have few
hypothesized harms, among them anxiety and depres-
sion; injuries (e.g., from physical activity); economic
costs; and the opportunity cost of delivering the inter-
vention. Nonetheless, explicitly assessing for actual
harms and clearly describing potential harms (e.g.,
stigma, paradoxical changes in behavioral or intermedi-
ate outcomes) are important to accurately evaluating the
evidence. This clarity will help assess if the paucity of
harms reported for behavioral counseling interventions is
due to the lack of harms or lack of evidence on harms.Timing
The duration of the intervention and its components (e.g.,
active intervention, maintenance or booster sessions) andSeptember 2015the timing of the measurement of outcomes are necessary
to understand the duration of beneﬁt and whether the
beneﬁt is limited to the period around the counseling or is
sustained beyond the end of the intervention. Often,
behavioral counseling trials have a limited duration of
follow-up such that little is known about the sustained
beneﬁt over time. Understanding the duration of beneﬁt
also affects the understanding of linkages between behav-
ioral and health outcomes, such that if changes in
behaviors are transient (and not sustained) there may
not be downstream health beneﬁts. Likewise, depending
on the timing and duration of the studies, health out-
comes may be limited to immediate outcomes (e.g.,
ultraviolet radiation [UV] protection counseling resulting
in less sunburn) versus delayed outcomes (i.e., UV
protection counseling decreasing risk of skin cancer).
Adherence to the intervention over time is also important
to describe, as real-world adherence is likely to be lower,
and generally decreases over time. Last, because many
counseling interventions are typically longitudinal in
nature (e.g., requiring multiple contacts over many weeks,
months, or even years), and behavior changes (e.g.,
initiating positive changes or terminating harmful behav-
iors) may occur over a long time horizon, longer-term
follow-up (with or without maintenance counseling) may
be needed to observe meaningful health beneﬁts.
In summary, synthesizing evidence across a body of
literature for any given behavioral intervention or behav-
ioral outcome is immensely challenging, largely because
of the complexity and heterogeneity across multiple
dimensions (i.e., studied populations, evaluated interven-
tions and comparators, measured outcomes, the relation-
ship of behavioral and intermediate outcomes to health
outcomes, and timing and persistence of beneﬁts). Under-
standing and communicating these challenges will allow
for advances in both primary (trials and observational
studies) and secondary (meta-analyses and systematic
reviews) research for behavioral counseling ﬁelds. These
challenges will require more attention and consistency on
the part of researchers to clearly and accurately report
details around the study design and ﬁndings; encourage
researchers (and funders) to establish reproducibility of
ﬁndings; and will require more-thoughtful syntheses
across individual studies to understand multicomponent
interventions with multiple outcomes.
Future Considerations
The primary question for participants at the USPSTF
Expert Forum and the major focus for this paper is whether
the standards of evidence for the net beneﬁts of behavioral
counseling intervention should be the same as those for
other preventive services such as screening or the use of
McNellis et al / Am J Prev Med 2015;49(3S2):S150–S157S156preventive medications. Currently, the primary standard of
evidence considered by the Task Force is evidentiary
support for each causal link in an analytic framework either
through direct or indirect evidence. From this perspective,
behavioral outcomes are acceptable if there is sufﬁcient
evidence from either clinical trials or longitudinal observa-
tional studies that behavior change results in improved
health outcomes. As discussed in the panel and summarized
thus far in this paper, obtaining evidence for health
outcomes is challenging from both methodologic and
conceptual perspectives.
The path forward for addressing methodologic chal-
lenges is relatively clear. This paper is not the ﬁrst to call
for the development of a common set of behavioral
outcome measures and measures of harm to be included
in behavioral counseling trials, which would ease the use
of current standards in evaluating the evidence base.6
Other known and applicable advances that the research
community can take are clearer descriptions of inter-
ventions for easier aggregation of studies for meta-
analysis, consideration of the representativeness of the
primary care population of interest in the development of
eligibility criteria, and inclusion of at least intermediate
outcomes in studies to help connect behavioral outcomes
to health indicators. Finally, the use of existing large-scale
longitudinal cohort studies to more carefully examine
linkages from behavior change to health outcomes over
time can provide support for accepting behavioral out-
comes as a reasonable standard of evidence.
With regard to conceptual challenges, the Task Force
can evaluate current methodologic standards against
three key issues. First, the Task Force is interested in
primary prevention, that is, interventions that can be
applied to asymptomatic individuals who do not have the
condition targeted for prevention. If we are able to
achieve behavioral change in these populations, it can
bode well for maintaining low risk status over time and
disrupt the behavior–disease relationship. Such an effect
would be evidenced by continued low rates of morbidity
and mortality. Conceptually, it is a challenge to demon-
strate improvements in health or reductions in negative
health outcomes when people are starting and staying
healthy over time. Second, comparative effectiveness
studies, which are not currently considered in evidence
reviews, could have a useful place in the development of
behavioral counseling recommendations to help deﬁne
more speciﬁcally the active ingredients of effective
interventions. Third, behavior change is complex, and
behavior change interventions can occur at multiple
levels in multiple contexts. Primary care interventions
that lead to successful behavior change may be necessary,
but not sufﬁcient, to improve population health.
Assuming some synergy among levels and types ofinterventions, it is important to consider the unique
contributions of behavioral counseling interventions
despite concerns about time to observed health effects.
Forum participants identiﬁed the potential advantages
of convening a consensus body to help guide the
development of evidence standards for behavioral coun-
seling interventions: a process in which the USPSTF can
play an important role. Such a consensus body (e.g., an
IOM committee) could provide standards that include1. common language for describing the components of
behavioral interventions;2. a parsimonious set of common behavioral outcome
measures for inclusion in behavioral counseling trials;3. a common set of potential harms to assess in
behavioral counseling intervention trials; and4. a catalogue of existing longitudinal cohort studies that
could provide insights to linkages between behavior
change and health outcomes over time.
In addition, a consensus body could articulate a
framework for developing evidence-based behavioral
counseling interventions that takes into consideration1. the methodologic rigor of the current Task Force
methodology;2. the challenge of demonstrating health outcome bene-
ﬁts both with regard to the goal of primary prevention
and the time frame of an RCT given the natural
history of chronic diseases with behavioral risk factors;3. the types and quality characteristics of comparative
effectiveness studies that could be considered in the
development of recommendations; and4. the importance of primary care– or health care–based
behavioral counseling interventions in the context of
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